Crude rates and adjusted hazard ratio for the incidence of Staphylococcus aureus infections comparing periods prescribed angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers. This evidence concerns the gene ACE and staphylococcus aureus infection.